Publications by authors named "Pierre Teillac"

Claim this Profile
V
VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
Jacqueline Rivet, Samia Mourah, Hideyuki Murata, Nicolas Mounier, Helena Pisonero, Pierre Teillac

Cancer· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion on 6-monthly luteinizing hormone-releasing hormone agonist treatment with the single-sphere depot system for prostate cancer.
Claude Schulman, Antonio Alcaraz, Richard Berges, Francesco Montorsi, Pierre Teillac

BJU Int· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion: prospective evaluation of patient's quality of life.
François Desgrandchamps, Stéphane Leroux, Vincent Ravery, Ghislain Bochereau, Philippe Menut, Pierre Teillac

J Endourol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prospective study of the quality of life after palliative urinary diversion by subcutaneous pyelovesical bypass (Detour ureteric prosthesis)].
Stéphane Leroux, François Desgrandchamps, Vincent Ravery, Ghislain Bochereau, Philippe Menut, Pierre Teillac

Prog Urol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Is the surgical training of French urologists more effective than that of urologists in other European countries?].
Stéphane Larre, Francis Dubosq, Selçuk Keskin, Yann Neuzillet, Albouy Baptiste, Pierre Teillac

Prog Urol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of patients presenting with LUTS/BPH in six European countries.
Annie Hutchison, Richard Farmer, Christopher Chapple, Richard Berges, Ludger Pientka, Pierre Teillac

Eur Urol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer.
Pierre Mongiat-Artus, Catherine Miquel, Jean-François Fléjou, Florence Coulet, Jérôme Verine, Pierre Teillac

Virchows Arch· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients.
Pierre Mongiat-Artus, Catherine Miquel, Madelon van der Aa, Olivier Buhard, Richard Hamelin, Pierre Teillac

Eur Urol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of pelvic stones larger than 20 mm: laparoscopic transperitoneal pyelolithotomy or percutaneous nephrolithotomy?
Paul Meria, Stéphane Milcent, François Desgrandchamps, Pierre Mongiat-Artus, Jean Marc Duclos, Pierre Teillac

Urol Int· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Analysis of the microsatellite instability gene mutation in the urothelial tumor of the upper urinary tract].
Pierre Mongiat-Artus, Catherine Miquel, Madelon van der Aa, Olivier Buhard, Richard Hamelin, Pierre Teillac

Prog Urol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
Alexandre R Zlotta, Pierre Teillac, Jean Pierre Raynaud, Claude C Schulman

Eur Urol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Renal cell carcinoma and trichloroethylene].
Francis Dubosq, Clemens Linke, Vincent Cardot, Paul Meria, François Desgrandchamps, Pierre Teillac

Prog Urol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic equivalence of a decapeptyl 3-month SR formulation with the 28-day SR formulation in patients with advanced prostate cancer.
Pierre Teillac, Christiaan F Heyns, Amir V Kaisary, Olivier Bouchot, Joëlle Blumberg

Horm Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal use.
Pierre Teillac, Aldo V Bono, Jacques Irani, Manfred P Wirth, Alexandre R Zlotta

Clin Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer.
Pierre Mongiat-Artus, Pierre Teillac

Expert Opin Pharmacother· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Value of a visual analogue scale for evaluation of the severity of symptoms of benign prostatic hyperplasia (BPH). Pilot study in two urology centres].
Pierre Teillac, François Rozet, Nicolas Terrier, Pierre Mongiat-Artus, Jean-Jacques Rambeaud

Prog Urol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis.
Frans Debruyne, Peter Boyle, Fernando Calais Da Silva, Jay G Gillenwater, Freddie C Hamdy, Pierre Teillac

Eur Urol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].
Frans Debruyne, Peter Boyle, Fernando Calais da Silva, Jay G Gillenwater, Freddie C Hamdy, Pierre Teillac

Prog Urol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapeutic prevention studies of prostate cancer.
Bob Djavan, Alexandre Zlotta, Claude Schulman, Pierre Teillac, Peter Iversen

J Urol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benign prostatic hyperplasia: a progressive disease of aging men.
Mark Emberton, Gerald L Andriole, Jean de la Rosette, Bob Djavan, Klaus Hoefner, Pierre Teillac

Urology· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Use of a previously transplanted kidney for second transplantation].
Edouard Tariel, François Desgrandchamps, Pierre Mongiat-Arthus, François Rozet, Christophe Legendre, Pierre Teillac

Prog Urol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive molecular detection of bladder cancer recurrence.
Najla Amira, Samia Mourah, François Rozet, Pierre Teillac, Jean Fiet

Int J Cancer· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
Frans Debruyne, Gary Koch, Peter Boyle, Fernando Calais Da Silva, Jay G Gillenwater, Pierre Teillac

Prog Urol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
Frans Debruyne, Gary Koch, Peter Boyle, Fernando Calais Da Silva, Jay G Gillenwater, Pierre Teillac

Eur Urol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Role of uropontin in calcium oxalate lithogenesis].
Pascal Paulhac, François Desgrandchamps, Jean-Philippe Dumas, Pierre Teillac, Alain Le Duc

Prog Urol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis